Medidata solutions, which provides an on-demand hosted technology platform for capturing and managing clinical trial data, filed with the SEC for an IPO on Monday. The company booked $109 million in LTM revenues and will apply to have its shares listed on the NASDAQ under the ticker MDSO. Citi and Credit Suisse are set to be the lead underwriters on the deal. No terms were disclosed in the initial filing.
